ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1353

Dietary Practices and Beliefs of Patients with Rheumatic Diseases and Relationship with Symptoms: Results of a Multicenter Cross-sectional Study

Domitille RENARD1, Sophie Tuffet2, Philippe Dieude3, Pascal Claudepierre4, Laure Gossec5, Bruno Fautrel6, Anna Molto7, Corinne MIceli8, Pascal Richette9, Emmanuel Maheu10, Claire Carette11, Sebastien Czernichow11, Chloe JAMAKORZYAN12, alexandra Rousseau2, Francis Berenbaum13, Catherine Beauvais14 and Jérémie SELLAM15, 1Sorbonne University Paris- Sant Antoine Hospital, Paris, France, 2Saint Antoine hospital, Paris, Ile-de-France, France, 3Université Paris Cité, Paris, France, 4Paris Est Creteil University, Creteil, France, 5Sorbonne Université, Paris, France, 6Sorbonne University Paris, France and Pierre Louis Institute of Epidemiology and Public Health, Paris, France, Paris, France, 7Rheumatology Department, Cochin Hospital, APHP, Paris, France, 8APHP, Paris, France, 9Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 10Hôpital Paris Saint Antoine, Moirans, Auvergne-Rhône-Alpes, France, 11Hôpital Européen Georges Pompidou, Paris, France, 12Hopital Begin, Saint-Mandé, France, 13Sorbonne University - Saint-Antoine hospital, Paris, France, 14Saint Antoine hospital, Paris, France, 15Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France

Meeting: ACR Convergence 2022

Keywords: diet, Osteoarthritis, rheumatoid arthritis, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Diet is a subject of questioning and beliefs among patients with rheumatic diseases. They are inclined to change their eating habits and sometimes follow unscientific advice in order to alleviate their symptoms. Thus, we want to investigate the dietary practices and beliefs of patients with rheumatic diseases and factors associated with these practices.

Methods: A cross-sectional multicenter study conducted in 6 university rheumatology departments enrolled patients with established inflammatory arthritis (IA) (rheumatoid arthritis (RA) axial spondyloarthritis (AxSpA)) or hand osteoarthritis (HOA), fulfilling ACR/EULAR2010, ASAS2009 and ACR1990 criteria, respectively, regardless of treatment and disease activity. Patients with celiac disease were excluded. Patients completed a self-administered questionnaire developed for the purpose of the study exploring dietary practices and patients’ perceived effects of diet, foods and beverages on their rheumatic symptoms (pain and fatigue). Univariate and multivariate analyses assessed associations between diet practices or effect of food on pain and the patients’ characteristics (sociodemographic, lifestyle, health beliefs and disease activity).

Results: 392 patients were included (123 patients with RA, 161 with AxSpA, and 108 with HOA) with a mean age of 56 years; 72% and 82% of patients with AxSpA and RA were treated with biologics, respectively.

26 % of patients were on or had been on at least one diet (30%, 24% and 22% of patients with AxSpA, RA and HOA respectively). The cow’s milk-free and gluten-free diets were the most followed by patients with IA (26.5% and 25.6% respectively) while the cow’s milk-free diet was the most followed in HOA patients (29%). Other diets were mainly fasting and lactose free. Among the patients who followed a diet, 51% reported a decrease in pain and 62% reported an improvement in their general condition. The median duration of diets was 12.0 [4.0 ; 30.0] months). Patients were mainly advised by friends and family (45%) or via internet (47%), less frequently by doctors (18%).

42% of patients declared at least one food or beverage increasing or decreasing pain. Dairy products, alcohol, red meat and sweet products more often increased pain, whereas green vegetables, fruits, fatty fish, nuts and turmeric more often decreased pain (figure 1 and 2).

In the multivariate analyses, the use of complementary and alternative medicine (CAM) was associated with dieting in AxSpA and HOA, but not in RA. However, CAM was not associated with a perceived effect of diet on pain. Health beliefs (positive or negative) and lack of support or information were associated with dieting or effect of food on pain (Table 1).

Conclusion: 26% of patients with rheumatic diseases followed or had followed an exclusion diet, most of time without doctor’s advice and 42 % of patients report an effect of foods on their symptoms with potentially pro or anti-inflammatory foods identified by patients. This study provides insights into the determinants of dietary practices, including health beliefs, patients’ perspective, and the use of CAM and may give clues on how to include diet in the management of rheumatic diseases.

Supporting image 1

Perceived effect of animal foods on pain in patients who reported that at least one food/beverage altered their pain (n=165).

Supporting image 2

Perceived effect of vegetable foods on pain in patients who reported that at least one food/beverage altered their pain (n=165)

Supporting image 3

Factors associated with dieting or with the effect of food on pain found after multivariate analysis for each disease
* model adjusted on age and covariates selected in univariate analysis (p-value<0.15) (stepwise model)


Disclosures: D. RENARD, None; S. Tuffet, None; P. Dieude, None; P. Claudepierre, AbbVie/Abbott, MSD, UCB, Pfizer, Lilly, Novartis, Janssen, Galapagos, Amegn, biogen; L. Gossec, Amgen, Lilly, Pfizer, Sandoz, UCB Pharma, AbbVie, Bristol Myers Squibb, Gilead, Janssen, Novartis, Samsung Bioepis, Sanofi-Aventis, Galapagos, GlaxoSmithKlein (GSK), Celltrion, MSD; B. Fautrel, Pfizer, Novartis, Roche, Sanofi-Aventis, SOBI, UCB; A. Molto, None; C. MIceli, None; P. Richette, AbbVie, Amgen, Biogen, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, Roche, Sanofi-Aventis, UCB; E. Maheu, None; C. Carette, None; S. Czernichow, None; C. JAMAKORZYAN, None; a. Rousseau, None; F. Berenbaum, 4Moving Biotech; C. Beauvais, None; J. SELLAM, None.

To cite this abstract in AMA style:

RENARD D, Tuffet S, Dieude P, Claudepierre P, Gossec L, Fautrel B, Molto A, MIceli C, Richette P, Maheu E, Carette C, Czernichow S, JAMAKORZYAN C, Rousseau a, Berenbaum F, Beauvais C, SELLAM J. Dietary Practices and Beliefs of Patients with Rheumatic Diseases and Relationship with Symptoms: Results of a Multicenter Cross-sectional Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/dietary-practices-and-beliefs-of-patients-with-rheumatic-diseases-and-relationship-with-symptoms-results-of-a-multicenter-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dietary-practices-and-beliefs-of-patients-with-rheumatic-diseases-and-relationship-with-symptoms-results-of-a-multicenter-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology